Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-28 | Relay Therapeutics, Inc. | Catinazzo Thomas
(Chief Financial Officer) |
S | Common Stock | D | 9102 | $5.95 - $6.06 | $54,904 |
| 2024-10-28 | Relay Therapeutics, Inc. | Bergstrom Donald A
(President, R&D) |
S | Common Stock | D | 2688 | $6.06 - $6.06 | $16,289 |
| 2024-10-28 | Relay Therapeutics, Inc. | Adams Brian
(Chief Legal Officer) |
S | Common Stock | D | 1632 | $6.06 - $6.06 | $9,889 |
| 2024-09-27 | Relay Therapeutics, Inc. | Rahmer Peter
(See remarks) |
S | Common Stock | D | 245 | $7.51 - $7.51 | $1,839 |
| 2024-09-27 | Relay Therapeutics, Inc. | Catinazzo Thomas
(Chief Financial Officer) |
S | Common Stock | D | 6457 | $7.46 - $7.51 | $48,183 |
| 2024-09-27 | Relay Therapeutics, Inc. | Bergstrom Donald A
(President, R&D) |
S | Common Stock | D | 648 | $7.51 - $7.51 | $4,866 |
| 2024-09-27 | Relay Therapeutics, Inc. | Adams Brian
(Chief Legal Officer) |
S | Common Stock | D | 295 | $7.51 - $7.51 | $2,215 |
| 2024-07-29 | Relay Therapeutics, Inc. | Catinazzo Thomas
(Chief Financial Officer) |
S | Common Stock | D | 10780 | $8.51 - $8.85 | $92,315 |
| 2024-07-29 | Relay Therapeutics, Inc. | Rahmer Peter
(See remarks) |
S | Common Stock | D | 42359 | $8.19 - $8.85 | $353,069 |
| 2024-07-29 | Relay Therapeutics, Inc. | Bergstrom Donald A
(President, R&D) |
S | Common Stock | D | 2698 | $8.85 - $8.85 | $23,877 |
| 2024-07-29 | Relay Therapeutics, Inc. | Adams Brian
(Chief Legal Officer) |
S | Common Stock | D | 1638 | $8.85 - $8.85 | $14,496 |
| 2024-07-25 | Relay Therapeutics, Inc. | Patel Sanjiv
(President and CEO) |
S | Common Stock | D | 86706 | $9.07 - $9.16 | $790,923 |
| 2024-07-25 | Relay Therapeutics, Inc. | Patel Sanjiv
(President and CEO) |
M | Common Stock | A | 86706 | $5.04 - $5.04 | $436,998 |
| 2024-06-27 | Relay Therapeutics, Inc. | Adams Brian
(Chief Legal Officer) |
S | Common Stock | D | 295 | $6.26 - $6.26 | $1,846 |
| 2024-06-10 | Relay Therapeutics, Inc. | Rubin Jami
(Director) |
M | Common Stock | A | 42242 | $5.04 - $5.04 | $212,899 |
| 2024-06-03 | Relay Therapeutics, Inc. | Rahmer Peter
(See remarks) |
S | Common Stock | D | 80909 | $6.47 - $7.06 | $542,447 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |